The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of ocrelizumab for the treatment of ...

A quarter-over-quarter comparison was not possible because the previous-quarter transcript was not available.

Debiopharm to present pre-clinical and clinical research advances in DDR inhibition, dual payload ADCs & AI-driven biomarkers at AACR 2026: Lausanne, Switzerland Thursday, April 1 ...

ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced that ...

The fictional cases — which now carry corrections but remain published — are 'a huge stain on medical literature,' says one ...

Traws Pharma Inc (TRAW) reports a remarkable financial turnaround in 2025, driven by strategic financing and promising developments in its flu program.

Serpin Pharma receives FDA IND approval for SP16, a novel therapy for chemotherapy-induced peripheral neuropathy. Phase ...

While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the ...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva,” the “Company” “we” or “us”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the ...

In the role, Szczepan will lead scientific and AI strategy across in silico predictive modeling, translational safety analytics, and data-driven drug development solutions. Building the Regulatory ...

Aurora Cannabis Inc. (the "Company" or "Aurora") , the Canadian-based leading global medical cannabis company, is pleased to announce it has acquired Safari Flower Company, an established EU GMP ...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva," the "Company" "we" or "us"), a late-stage pharmaceutical company developing therapies ...